Thursday, June 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of California”

3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,494
Index total 30,257
Page 49 / 146

Quick answer

This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,494 results for “The Regents of the University of California” · 30,257 patents in full index Clear search

  1. US 10307386

    Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

    The Regents of the University of California · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  2. US 10301651

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted May 28, 2019 · Expires May 23, 2039

    granted

  3. US 10301626

    Catalytic strands of minimal hammerhead ribozymes and methods of using the same

    The Regents of the University of California · Granted May 28, 2019 · Expires May 23, 2039

    granted

  4. US 10301365

    Met e 1 tropomyosin variants for use in allergen-specific immunotherapy

    The Regents of the University of California · Granted May 28, 2019 · Expires May 23, 2039

    granted

  5. US 10300152

    Enzyme-encapsulated nanoparticle platform

    The Regents of the University of California · Granted May 28, 2019 · Expires May 23, 2039

    granted

  6. US 10300117

    Methods and compositions for improved cognition

    The Regents of the University of California · Granted May 28, 2019 · Expires May 23, 2039

    granted

  7. US 10300043

    Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereof

    The Regents of the University of California · Granted May 28, 2019 · Expires May 23, 2039

    granted

  8. US 10300073

    Use of CDK9 and BRD4 inhibitors to inhibit inflammation

    The Regents of the University of California · Granted May 28, 2019 · Expires May 23, 2039

    granted

  9. US 10292992

    Selective high-affinity polydentate ligands and methods of making such

    The Regents of the University of California · Granted May 21, 2019 · Expires May 16, 2039

    granted

  10. US 10293077

    Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use

    The Regents of the University of California · Granted May 21, 2019 · Expires May 16, 2039

    granted

  11. US 10287355

    Methods and compositions for modulating lymphangiogenesis, E.G., to treat transplant rejection, in a subject

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  12. US 10287312

    Cyclic peroxides as prodrugs for selective delivery of agents

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  13. US 10285962

    Glutarate compounds for treating ischemia-reperfusion injuries

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  14. US 10285952

    Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  15. US 10285940

    Multicomponent, internally structured nanoemulsions and methods of production

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  16. US 10286079

    Modified cytotoxins and their therapeutic use

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  17. US 10280197

    Discovery of the first selective C5A receptor 2 (C5L2/C5AR2) ligands

    The Regents of the University of California · Granted May 7, 2019 · Expires May 2, 2039

    granted

  18. US 10279010

    Methods and compositions for modulating myofibroblast activities

    The Regents of the University of California · Granted May 7, 2019 · Expires May 2, 2039

    granted

  19. US 10273333

    Substituted polyesters by thiol-ene modification: rapid diversification for therapeutic protein stabilization

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  20. US 10272173

    Radioactive bone cement

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  21. US 10272093

    Use of H3K9me3 modulation for enhancing cognitive function

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  22. US 10272055

    Therapeutic compounds and methods

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  23. US 10272037

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  24. US 10272034

    Auris formulations for treating otic diseases and conditions

    The Regents of the University of California · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.